MARKETSnap
  • Gainers &
    Losers
  • Most Active &
    More
  • 52-Week
    High/Low
  • P/E
    Ratios
    • Large Caps
    • Absolute
    • Total Market PE
  • Stocks
    Performance
    • Large Caps
    • Absolute
  • Industries
    Performance
    • Industry
    • Sector
  • Dividends
  • 📅 Calendar
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 🔧 Tools
    • 💰 Intrinsic Value Calculator
    • 📈 Compounding Calculator
    • 🤖 Stock Pick Screener
  • More
    • Investment Compounding Calculator
    • Commodities
    • Currencies
    • Economic Indicators
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
HLMA.L stock logo

HLMA.L

Halma plc

$4477
70
 (1.59%)
[ms_data_label text=’Delayed data’]
Exchange:  LSE
Market Cap:  16.91B
Shares Outstanding:  379.157M
Overview
Earnings
Financials
Valuation
Chart

About The Company

Sector:  Industrials
Industry:  Conglomerates
   
CEO:  Marc Arthur Ronchetti
Full Time Employees:  8000
Address: 
Misbourne Court
Amersham
HP7 0DE
GB
Website:  https://www.halma.com
Halma plc, through its subsidiaries, provides technology solutions in the safety, health, and environmental markets. It operates through three segments: Safety, Environmental & Analysis, and Medical. The Safety segment provides fire detection, specialist fire suppression, elevator safety, security sensors, people and vehicle flow technologies, specialized interlocks that control critical processes safely, and explosion protection and corrosion monitoring systems. This segment serves elevator safety, fire suppression, people and vehicle flow, fire detection, pressure management, industrial access control, and safe storage and transfer markets. The Environmental & Analysis segment offers optical, optoelectronic, and spectral imaging systems; water, air and gases monitoring technologies; instruments that detect hazardous gases and analyses air quality; and systems for water analysis and treatment. It serves the optical analysis, water analysis and treatment, gas detection, and environmental monitoring markets. The Medical segment provides critical fluidic components used by medical diagnostics and original equipment manufacturers; laboratory devices and systems that provide information to understand patient health and enable providers to make decisions across the continuum of care; technologies and solutions to enable in-vitro diagnostic systems and life-science discoveries and development; and technologies that enable positive outcomes across clinical specialties. This segment serves the life sciences, health assessment, and therapeutic solutions market. The company was incorporated in 1894 and is headquartered in Amersham, the United Kingdom.

Click to read more…

Revenue Segmentation

🔒 You are currently logged out

Login

It’s free

EPS

Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.

Log in to continue

Log in for the full EPS chart and links to analyst estimates.

Login — it's free
View full analyst estimates

Earnings Call

No earnings call materials on file for this symbol yet.

Log in to continue

Log in to read the full transcript and AI-generated earnings summaries.

Login — it's free
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates

Income Statement

Year202320242025
Revenue1,852,8002,034,1002,248,100
Gross Profit877,9001,010,2001,133,600
EBITDA410,600475,500537,300
Operating Income321,500367,700409,500
Net Income234,500268,800296,400

Log in to continue

Log in to see the income statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Balance Sheet

Year202320242025
Total Assets2,788,4002,999,9003,258,600
Total Liabilities1,188,3001,263,4001,359,200
Total Stockholders Equity1,598,8001,736,5001,899,400
Total Debt766,200795,900849,000
Cash and Cash Equivalents169,500142,700313,200

Log in to continue

Log in to see the balance sheet and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Cash Flow Statement

Year202320242025
Operating Cash Flow241,200385,000492,400
Capital Expenditure-45,900-51,600-59,400
Free Cash Flow195,300333,400433,000
Net Income234,500268,800409,500
Net Change in Cash12,100-26,100170,300

Log in to continue

Log in to see the cash flow statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Analyst Estimates

Fiscal Year2029Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Low)3,115,327.832Full AccessFull AccessFull AccessFull Access
Estimated Revenue (High)3,407,333.873Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Avg)3,221,106.692Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Low)752,163.487Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (High)822,665.307Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Avg)777,702.692Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Low)542,574.529Full AccessFull AccessFull AccessFull Access
Estimated Net Income (High)609,370.609Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Avg)566,771.281Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Low)995,143.393Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (High)1,088,420.216Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Avg)1,028,932.817Full AccessFull AccessFull AccessFull Access
Estimated EPS (Avg)1.490Full AccessFull AccessFull AccessFull Access
Estimated EPS (High)1.610Full AccessFull AccessFull AccessFull Access
Estimated EPS (Low)1.430Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated Revenue)9Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated EPS)4Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in and subscribe to Full Access to see up to 5 years of analyst estimates.

Login — it's free

(* All numbers are in thousands)

Current Key Metrics

?Revenue
 (TTM)
: 
  ?P/S
 (TTM)
: 
9.35
?Net Income
 (TTM)
: 
  ?P/E
 (TTM)
: 
63.94
?Enterprise Value
 (TTM)
: 
17.705B  ?EV/FCF
 (TTM)
: 
61.09
?Dividend Yield
 (TTM)
: 
0.01  ?Payout Ratio
 (TTM)
: 
0.26
?ROE
 (TTM)
: 
0.14  ?ROIC
 (TTM)
: 
0.1
?Net Debt
 (TTM)
: 
  ?Debt/Equity
 (TTM)
: 
0.43
?P/B
 (TTM)
: 
8.58  ?Current Ratio
 (TTM)
: 
2.18

Log in to continue

Log in to see all key valuation metrics and ratios for this symbol.

Login — it's free

Forward P/E Ratios

?

Forward P/E (Avg EPS estimate) — log in with Full Access for high/low estimates and the interactive table.

Forward P/E 1YFull AccessFull AccessFull AccessFull Access
3,013.37Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in with Full Access for forward P/E high/low estimates and the full multi-year table.

Login — it's free

SWOT Analysis

🔒 You are currently logged out

Login

It's free

At what price to buy it? -
Intrinsic Value Calculator

This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.


Calculate HLMA Intrinsic Value

Common questions about HLMA.L valuation

Is Halma plc (HLMA.L) overvalued or undervalued right now?

MARKETSnap estimates intrinsic value for Halma plc (HLMA.L) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.

Is HLMA.L a buy, hold, or sell for long-term investors?

MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether HLMA.L trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.

What is HLMA.L’s P/E ratio?

You can see HLMA.L’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.

How is intrinsic value calculated for HLMA.L?

MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.

Is HLMA.L a good long-term investment?

Whether HLMA.L fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.

HLMA.L

1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.

[ms_data_label text="Daily snapshot"]

1.59
MARKETSnap

Trading Metrics:

[ms_session_rows_unavailable]
Open: [ms_cell_or_dash table='trading_quote' column='open']   Previous Close: [ms_cell_or_dash table='trading_quote' column='previousClose']
Day Low: [ms_cell_or_dash table='trading_quote' column='dayLow']   Day High: [ms_cell_or_dash table='trading_quote' column='dayHigh']
Year Low: 2768   Year High: 4579.5
Price Avg 50: 4038.6   Price Avg 200: 3616.04
Volume: 117691   Average Volume: 1.274M

Log in to continue

Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.

Login — it's free
Could not create stock discussion for HLMA

Relevant news

DISCLAIMER: The stock market data provided on this website is for informational purposes only and is not intended for trading purposes. While we strive to provide accurate and timely information, we cannot guarantee that the information is accurate at the moment it is received or that it will continue to be accurate in the future. We are not responsible for any actions taken based on the information provided on this website. Always consult with a licensed financial professional before making any investment decisions.
Terms of Service

Copyright © 2025 MarketSnap. All rights reserved.

Contact Us

Privacy Policy

Cookie Policy

Terms of Service

Hover Image
MARKETSnap

Market

🇺🇸 United States
  • Gainers & Losers
  • Most Active & More
  • 52-Week High/Low
  • Dividends
    • Large Caps
    • Absolute
    • Total Market PE
    • Large Caps
    • Absolute
    • Industry
    • Sector
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 💰 Stock intrinsic value Calculator
  • 📈 Investment Compounding Calculator
  • 🤖 Stock Pick Screener
  • 📋 Watchlist & Portfolio
    • Commodities
    • Currencies
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
  • Nexus
  • Login Login
  • Profile Profile
  • Watchlists Watchlists
  • My Valuations My Valuations
  • Settings Settings

Media

Watch Listen Read